The FDA and Prescription Pancreatic Enzyme Product Cost

被引：7
作者：
Gardner, Timothy B. [1 ]
Munson, Jeffrey C. [1 ]
Morden, Nancy E. [1 ]
机构：
[1] Geisel Sch Med Dartmouth, Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2014年 / 109卷 / 05期
关键词：
D O I：
10.1038/ajg.2013.430
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：624 / 625
页数：2
相关论文
共 5 条
  • [1] Food and Drug Administration, RUL HIST OTC EX PANC
  • [2] Food and Drug Administration, UDP QUEST ANSW HEALT
  • [3] Pancreatic Enzyme Products: Digesting the Changes
    Giuliano, Christopher A.
    Dehoorne-Smith, Michelle L.
    Kale-Pradhan, Pramodini B.
    [J]. ANNALS OF PHARMACOTHERAPY, 2011, 45 (05) : 658 - 666
  • [4] TREATMENT FAILURE AFTER SUBSTITUTION OF GENERIC PANCRELIPASE CAPSULES - CORRELATION WITH INVITRO LIPASE ACTIVITY
    HENDELES, L
    DORF, A
    STECENKO, A
    WEINBERGER, M
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (18): : 2459 - 2461
  • [5] Incentives for Drug Development - The Curious Case of Colchicine
    Kesselheim, Aaron S.
    Solomon, Daniel H.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (22) : 2045 - 2047
1